Amir-Babak Sioofy-Khojine (Amirbabak Sioofy-Khojine, A B Sioofy-Khojine)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Microorganisms

Diabetic medicine : a journal of the British Diabetic Association

Diabetes

Science advances

Faculty of medicine and life technologies, Tampere University

University of Glasgow School of Life Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculty of medicine and life technologies, Tampere University Jan 01 2019

Finland

Senior scientist :: Virology

University of Tampere Jan 01 2018 - Dec 31 2018

Finland

Senior scientist :: Virology and Vaccine Research Center

Tampereen Yliopisto Oct 01 2010 - Dec 31 2017

Finland

Post doctoral fellow :: Virology and Vaccine research center

University of Tabriz College of Veterinary Medicine

Iran

lecturer, Associate professor :: Pathobiology

Education History

University of Glasgow School of Life Sciences

United Kingdom

PHD :: Virology

Publications

Amir-Babak Sioofy-Khojine, Jussi P Lehtonen, Noora Nurminen, Jutta E Laiho, Jorma Toppari, Riitta Veijola, Johanna Lempainen, Jorma Ilonen, Mikael Knip, Heikki Hyöty
HLA-DQ-conferred risk for type 1 diabetes does not alter neutralizing antibody response to a widely used enterovirus vaccine, the poliovirus vaccine. Journal of medical virology (2023)
Amir-Babak Sioofy-Khojine, Sarah J Richardson, Jonathan M Locke, Sami Oikarinen, Noora Nurminen, Antti-Pekka Laine, Kate Downes, Johanna Lempainen, John A Todd, Riitta Veijola, Jorma Ilonen, Olli H Laitinen, Noel G Morgan, Heikki Hyöty, Mark Peakman, Martin Eichmann
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage. Diabetologia 65 (10) (2022)
Virginia M Stone, Marta Butrym, Minna M Hankaniemi, Amir-Babak Sioofy-Khojine, Vesa P Hytönen, Heikki Hyöty, Malin Flodström Tullberg
Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect. Diabetes 70 (12) (2021)
Anni Honkimaa, Bryn Kimura, Amir-Babak Sioofy-Khojine, Jake Lin, Jutta Laiho, Sami Oikarinen, Heikki Hyöty
Genetic Adaptation of Coxsackievirus B1 during Persistent Infection in Pancreatic Cells. Microorganisms 8 (11) (2020)
Virginia M Stone, Minna M Hankaniemi, Johanna Lempainen, Amir-Babak Sioofy-Khojine, Ang Lin, I M Diaz Lozano, M A Mazur, V Marjomäki, Karin Loré, Heikki Hyöty, Vesa Pekka Hytönen, Malin Flodström Tullberg
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Science advances 6 (19) (2020)
Minna M Hankaniemi, Mo A Baikoghli, Virginia M Stone, Li Xing, Outi Väätäinen, Saana Soppela, Amir-Babak Sioofy-Khojine, Niila V V Saarinen, Tingwei Ou, Brandon Anson, Heikki Hyöty, Varpu S Marjomaki, Malin Flodström Tullberg, R Holland Cheng, Vesa Pekka Hytönen, Johanna Lempainen
Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine. Microorganisms 8 (9) (2020)
Amir-Babak Sioofy-Khojine, Anni Honkimaa, Heikki Hyöty
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses. Diabetic medicine : a journal of the British Diabetic Association 37 (11) (2019)
Amir-Babak Sioofy-Khojine, Sami Oikarinen, Hanna Honkanen, Heini Huhtala, Jussi P Lehtonen, Thomas Briese, Heikki Hyöty, null null
Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes. PloS one 13 (9) (2018)

Amir-Babak Sioofy-Khojine.css-eqlu8i{font-size:small;padding-left:4px;} (Amirbabak Sioofy-Khojine, A B Sioofy-Khojine)

Publication Activity (10 Years)

Top Topics

Top Venues

Amir-Babak Sioofy-Khojine (Amirbabak Sioofy-Khojine, A B Sioofy-Khojine)